A randomized clinical trial in bronchogenic small-cell carcinoma evaluating alternating maintenance therapy of vincristine, adriamycin, procarbazine, and etoposide (VAPE) with cyclophosphamide, CCNU, and methotrexate (CCM) versus CCM maintenance alo (Q72848577)
Jump to navigation
Jump to search
scientific article published on 01 December 1994
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized clinical trial in bronchogenic small-cell carcinoma evaluating alternating maintenance therapy of vincristine, adriamycin, procarbazine, and etoposide (VAPE) with cyclophosphamide, CCNU, and methotrexate (CCM) versus CCM maintenance alo |
scientific article published on 01 December 1994 |
Statements
A randomized clinical trial in bronchogenic small-cell carcinoma evaluating alternating maintenance therapy of vincristine, adriamycin, procarbazine, and etoposide (VAPE) with cyclophosphamide, CCNU, and methotrexate (CCM) versus CCM maintenance alone in complete responders following VAPE induction and late intensification (English)
L E Broder
K S Sridhar
O S Selawry
K N Charyulu
R K Rao
M J Saldana
E J Donnelly
1 December 1994